# Medpace Holdings, Inc. (MEDP) FY2026 Q2 Balance Sheet

- Company: Medpace Holdings, Inc. (MEDP)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-23, accession number 0001668397-26-000025
- Page: https://plicit.ai/financials/medp/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/medp-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 2,057,181,000 US dollars
- **Current assets**: 1,050,285,000 US dollars
- **Non-current assets**: 1,006,896,000 US dollars
- **Liabilities**: 1,623,320,000 US dollars
- **Current liabilities**: 1,435,429,000 US dollars
- **Non-current liabilities**: 187,891,000 US dollars
- **Equity**: 433,861,000 US dollars
- **Cash and cash equivalents**: 502,688,000 US dollars
- **Accounts receivable and unbilled, net (includes $2.9 million and $3.5 million with related parties at June 30, 2026 and December 31, 2025, respectively)**: 441,797,000 US dollars
- **Prepaid expenses and other current assets**: 105,800,000 US dollars
- **Goodwill**: 662,396,000 US dollars
- **Property and equipment, net**: 157,114,000 US dollars
- **Operating lease right-of-use assets**: 125,849,000 US dollars
- **Intangible assets, net**: 33,110,000 US dollars
- **Other assets**: 25,196,000 US dollars
- **Deferred income taxes**: 3,231,000 US dollars
- **Advanced billings (includes $13.1 million and $12.3 million with related parties at June 30, 2026 and December 31, 2025, respectively)**: 904,722,000 US dollars
- **Accrued expenses**: 451,076,000 US dollars
- **Other current liabilities**: 42,104,000 US dollars
- **Accounts payable (includes $0.1 million and $0.3 million with related parties at June 30, 2026 and December 31, 2025, respectively)**: 37,527,000 US dollars
- **Operating lease liabilities**: 120,100,000 US dollars
- **Other long-term liabilities**: 59,584,000 US dollars
- **Deferred income tax liability**: 8,207,000 US dollars
- **Additional paid-in capital**: 964,183,000 US dollars
- **Common stock - $0.01 par-value; 250,000,000 shares authorized at June 30, 2026 and December 31, 2025; 27,910,605 and 28,370,780 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively**: 279,000 US dollars
- **Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2026 and December 31, 2025**: 0 US dollars
- **Accumulated deficit**: negative 511,368,000 US dollars
- **Treasury stock - 69,593 and 69,623 shares at June 30, 2026 and December 31, 2025, respectively**: negative 12,151,000 US dollars
- **Accumulated other comprehensive loss**: negative 7,082,000 US dollars
- **Gross equity (calculated)**: 964,462,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.